Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential Applications of NRF2 Modulators in Cancer Therapy
Emiliano Panieri, Aleksandra Buha Djordjević, Pelin Telkoparan‐Akillilar, et al.
Antioxidants (2020) Vol. 9, Iss. 3, pp. 193-193
Open Access | Times Cited: 130

Showing 26-50 of 130 citing articles:

The Role of Toxic Metals and Metalloids in Nrf2 Signaling
Aleksandra Buha Djordjević, Katarina Baralić, Danijela Đukić-Ćosić, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 630-630
Open Access | Times Cited: 52
Potent Natural Antioxidant Carveol Attenuates MCAO-Stress Induced Oxidative, Neurodegeneration by Regulating the Nrf-2 Pathway
Imran Riaz Malik, Fawad Ali Shah, Tahir Ali, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 51
Nrf2 in Cancer, Detoxifying Enzymes and Cell Death Programs
Tabitha Jenkins, Jérôme Gouge
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1030-1030
Open Access | Times Cited: 46
Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy
Zerrin Sezgin Bayındır, Sonia Losada‐Barreiro, Carlos Bravo‐Díaz, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 685-685
Open Access | Times Cited: 44
Nrf2, the Major Regulator of the Cellular Oxidative Stress Response, is Partially Disordered
Nadun C. Karunatilleke, Courtney S. Fast, Vy Ngo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7434-7434
Open Access | Times Cited: 41
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Rajni Kant, Rajesh Manne, Mohammad Anas, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 1158-1174
Open Access | Times Cited: 36
The Role of Organosulfur Compounds as Nrf2 Activators and Their Antioxidant Effects
Melford C. Egbujor, Maria Petrosino, Karim Zuhra, et al.
Antioxidants (2022) Vol. 11, Iss. 7, pp. 1255-1255
Open Access | Times Cited: 35
Nrf2/HO-1 Signaling Stimulation through Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) Provides Neuroprotection in Ethidium Bromide-Induced Experimental Model of Multiple Sclerosis
Shubham Upadhayay, Sidharth Mehan, Aradhana Prajapati, et al.
Genes (2022) Vol. 13, Iss. 8, pp. 1324-1324
Open Access | Times Cited: 31
MYH9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway
Guo-Rung You, Joseph T. Chang, Yan-Liang Li, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2855-2855
Open Access | Times Cited: 29
Seedless black Vitis vinifera polyphenols suppress hepatocellular carcinoma in vitro and in vivo by targeting apoptosis, cancer stem cells, and proliferation
Nadia Z. Shaban, Walaa Hegazy, Marwa M. Abu‐Serie, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116638-116638
Open Access | Times Cited: 6
Biological and therapeutic activities of thymoquinone: Focus on the Nrf2 signaling pathway
Marjan Talebi, Mohsen Talebi, Tahereh Farkhondeh, et al.
Phytotherapy Research (2020) Vol. 35, Iss. 4, pp. 1739-1753
Closed Access | Times Cited: 48
Nrf2 overexpression increases risk of high tumor mutation burden in acute myeloid leukemia by inhibiting MSH2
Ping Liu, Dan Ma, Ping Wang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Imperatorin Interferes with LPS Binding to the TLR4 Co-Receptor and Activates the Nrf2 Antioxidative Pathway in RAW264.7 Murine Macrophage Cells
Mei-Hsuen Huang, Yu‐Hsien Lin, Ping‐Chiang Lyu, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 362-362
Open Access | Times Cited: 34
Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo
Venugopal R. Bovilla, Mahadevaswamy G. Kuruburu, Vidya G. Bettada, et al.
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1119-1119
Open Access | Times Cited: 34
The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and β-TrCP-NRF2 interactions in cancer chemoresistance
Rohini Srivastava, Raquel Fernández-Ginés, José Antonio Encinar, et al.
Free Radical Biology and Medicine (2022) Vol. 192, pp. 246-260
Open Access | Times Cited: 23
Naringin against doxorubicin‐induced hepatotoxicity in mice through reducing oxidative stress, inflammation, and apoptosis via the up‐regulation of SIRT1
Yan Xi, Zhongchao Chi, Xufeng Tao, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 5, pp. 1153-1161
Open Access | Times Cited: 16
Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management
Vasiliki Katsi, Ilias Papakonstantinou, Konstantinos Tsioufis
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11786-11786
Open Access | Times Cited: 16
Emerging Role of NRF2 Signaling in Cancer Stem Cell Phenotype
Steffanus Pranoto Hallis, Jin Myung Kim, Mi‐Kyoung Kwak
Molecules and Cells (2023) Vol. 46, Iss. 3, pp. 153-164
Open Access | Times Cited: 15
Alkaloids as Natural NRF2 Inhibitors: Chemoprevention and Cytotoxic Action in Cancer
Darinka Gjorgieva Ackova, Viktorija Maksimova, Katarina Smilkov, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 850-850
Open Access | Times Cited: 15
Ferroptosis: Molecular perspective, cellular influence, cancer manifestation, and therapeutic potentials
Pawan Kumar Pandey, Saurabh Bhorkade, Shikha Jha, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 105998-105998
Closed Access | Times Cited: 5
Targeting the Redox Landscape in Cancer Therapy
Dilip Narayanan, Sana Ma, Dennis Özcelik
Cancers (2020) Vol. 12, Iss. 7, pp. 1706-1706
Open Access | Times Cited: 35
Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
Emiliano Panieri, Luciano Saso
Antioxidants and Redox Signaling (2021) Vol. 34, Iss. 18, pp. 1428-1483
Closed Access | Times Cited: 30
The multifaceted role of NRF2 in cancer progression and cancer stem cells maintenance
Bo-Hyun Choi, Jin Myung Kim, Mi‐Kyoung Kwak
Archives of Pharmacal Research (2021) Vol. 44, Iss. 3, pp. 263-280
Closed Access | Times Cited: 30
Adaptive Changes Allow Targeting of Ferroptosis for Glioma Treatment
Renxuan Huang, Rui Dong, Nan Wang, et al.
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 7, pp. 2055-2074
Closed Access | Times Cited: 30
Beyond direct Nrf2 activation; reinvestigating 1,2,4-oxadiazole scaffold as a master key unlocking the antioxidant cellular machinery for cancer therapy
Mohammed Salah Ayoup, Marwa M. Abu‐Serie, Hamida Abdel‐Hamid, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113475-113475
Closed Access | Times Cited: 30

Scroll to top